Oncology/Genetics| Volume 172, ISSUE 2, P670-676, August 2022

Perioperative optimization with nutritional supplements in patients undergoing gastrointestinal surgery for cancer: A randomized, placebo-controlled feasibility clinical trial



      Perioperative nutritional supplementation may improve outcomes. Trials have not investigated the role of combination strategy using different types of nutritional supplements.


      We conducted a single-site randomized pilot trial, among gastrointestinal cancer patients undergoing surgery, comparing perioperative nutritional supplements versus placebo (1 placebo to each supplement), to determine feasibility of a larger trial. Intervention, administered in sequence, included: protein supplementation (preoperative day 30–6), protein supplementation rich in arginine and omega-6 (preoperative day 5–1, and postoperative day 1–5), and carbohydrate loading (surgery day). Primary outcome was enrollment. Secondary outcomes included participant compliance with study supplements (target ≥70% of total packets). We planned protocol modifications to improve enrollment and compliance. Postoperative complications were described.


      Over 18 months, 495 patients were screened, 144 were deemed eligible, and 71 consented to participate, resulting in an enrollment fraction of 71/144 (49%, 95% confidence interval: 41%–57%). ‘Too much burden’ was the most common reason for refusal to participate (34%). Participants’ median overall compliance with study packets was 80%. Protocol modifications (decreasing the interval from enrollment to surgery from 4 to 2 weeks and decreasing length of baseline assessment) did not impact enrollment or compliance. Postoperative complications were similar between control (18/31 [58%, 95% confidence interval: 4–74]), and intervention (22/34 [65%, 95% confidence interval: 48–79]) arms, with a higher proportion of infectious complications in the control arm (16/31, 52% vs 12/34, 35%).


      Results from this pilot suggest a larger phase III trial is feasible. Postoperative infectious complications were common, making this a suitable outcome of interest.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Zhang B.
        • Najarali Z.
        • Ruo L.
        • et al.
        Effect of perioperative nutritional supplementation on postoperative complications-systematic review and meta-analysis.
        J Gastrointest Surg. 2019; 23: 1682-1693
        • Hamza N.
        • Darwish A.
        • O’Reilly D.A.
        • et al.
        Perioperative enteral immunonutrition modulates systemic and mucosal immunity and the inflammatory response in patients with periampullary cancer scheduled for pancreaticoduodenectomy: a randomized clinical trial.
        Pancreas. 2015; 44: 41-52
        • Horie H.
        • Okada M.
        • Kojima M.
        • Nagai H.
        Favorable effects of preoperative enteral immunonutrition on a surgical site infection in patients with colorectal cancer without malnutrition.
        Surg Today. 2006; 36: 1063-1068
        • Soop M.
        • Nygren J.
        • Myrenfors P.
        • Thorell A.
        • Ljungqvist O.
        Preoperative oral carbohydrate treatment attenuates immediate postoperative insulin resistance.
        Am J Physiol Endocrinol Metab. 2001; 280: E576-E583
        • Dabrowska A.M.
        • Slotwiński R.
        The immune response to surgery and infection.
        Cent Eur J Immunol. 2014; 39: 532-537
        • Angka L.
        • Khan S.T.
        • Kilgour M.K.
        • Xu R.
        • Kennedy M.A.
        • Auer R.C.
        Dysfunctional natural killer cells in the aftermath of cancer surgery.
        Int J Mol Sci. 2017; 18: 1787
        • Suzuki D.
        • Furukawa K.
        • Kimura F.
        • et al.
        Effects of perioperative immunonutrition on cell-mediated immunity, T helper type 1 (Th1)/Th2 differentiation, and Th17 response after pancreaticoduodenectomy.
        Surgery. 2010; 148: 573-581
        • Zhu X.
        • Herrera G.
        • Ochoa J.B.
        Immunosupression and infection after major surgery: a nutritional deficiency.
        Crit Care Clin. 2010; 26 (ix): 491-500
        • Calder P.C.
        BMJ. 2003; 327: 117-118
        • Thorell A.
        • Nygren J.
        • Ljungqvist O.
        Insulin resistance: a marker of surgical stress.
        Curr Opin Clin Nutr Metab Care. 1999; 2: 69-78
        • Gillis C.
        • Carli F.
        Promoting perioperative metabolic and nutritional care.
        Anesthesiology. 2015; 123: 1455-1472
        • Scott M.J.
        • Baldini G.
        • Fearon K.C.
        • et al.
        Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 1: pathophysiological considerations.
        Acta Anaesthesiol Scand. 2015; 59: 1212-1231
        • Mortensen K.
        • Nilsson M.
        • Slim K.
        • et al.
        Consensus guidelines for enhanced recovery after gastrectomy: Enhanced Recovery After Surgery (ERAS(R)) Society recommendations.
        Br J Surg. 2014; 101: 1209-1229
        • Malnuttition Advisory Group (MAG), a Standing Committee of BAPEN
        The “MUST” report. Nutritional screening of adults: a multidisciplinary responsibility.
        • Serrano P.E.
        • Parpia S.
        • Nair S.
        • et al.
        Perioperative Optimization With Nutritional Supplements in Patients Undergoing Gastrointestinal Surgery for Cancer (PROGRESS): protocol for a feasibility randomized controlled trial.
        JMIR Res Protoc. 2018; 7e10491
        • McClave S.A.
        • Taylor B.E.
        • Martindale R.G.
        • et al.
        Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.).
        JPEN J Parenter Enteral Nutr. 2016; 40: 159-211
        • Weimann A.
        • Braga M.
        • Carli F.
        • et al.
        ESPEN guideline: clinical nutrition in surgery.
        Clin Nutr. 2017; 36: 623-650
        • Dindo D.
        • Demartines N.
        • Clavien P.A.
        Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.
        Ann Surg. 2004; 240: 205-213
        • Slankamenac K.
        • Graf R.
        • Barkun J.
        • Puhan M.A.
        • Clavien P.A.
        The comprehensive complication index: a novel continuous scale to measure surgical morbidity.
        Ann Surg. 2013; 258: 1-7
        • Aaronson N.K.
        • Ahmedzai S.
        • Bergman B.
        • et al.
        The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.
        J Natl Cancer Inst. 1993; 85: 365-376
        • Cella D.F.
        • Tulsky D.S.
        • Gray G.
        • et al.
        The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.
        J Clin Oncol. 1993; 11: 570-579
        • Borloni B.
        • Huettner H.
        • Schuerholz T.
        Preoperative nutritional conditioning: why, when and how.
        Visc Med. 2019; 35: 299-304
        • Osoba D.
        • Rodrigues G.
        • Myles J.
        • Zee B.
        • Pater J.
        Interpreting the significance of changes in health-related quality-of-life scores.
        J Clin Oncol. 1998; 16: 139-144
        • Ringash J.
        • O'Sullivan B.
        • Bezjak A.
        • Redelmeier D.A.
        Interpreting clinically significant changes in patient-reported outcomes.
        Cancer. 2007; 110: 196-202
        • Wright J.R.
        • Bouma S.
        • Dayes I.
        • Sussman J.
        • Simunovic M.R.
        • Levine M.N.
        • et al.
        The importance of reporting patient recruitment details in phase III trials.
        J Clin Oncol. 2006; 24 (843–545)
        • Morisky D.E.
        • Green L.W.
        • Levine D.M.
        Concurrent and predictive validity of a self-reported measure of medication adherence.
        Med Care. 1986; 24: 67-74
        • Glowka T.R.
        • Webler M.
        • Matthaei H.
        • et al.
        Delayed gastric emptying following pancreatoduodenectomy with alimentary reconstruction according to Roux-en-Y or Billroth-II.
        BMC Surg. 2017; 17: 24
        • Serrano P.E.
        • Herman J.M.
        • Griffith K.A.
        • et al.
        Quality of life in a prospective, multicenter phase 2 trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation in patients with resectable or borderline resectable pancreatic adenocarcinoma.
        Int J Radiat Oncol Biol Phys. 2014; 90: 270-277
        • Ross S.
        • Grant A.
        • Counsell C.
        • Gillespie W.
        • Russell I.
        • Prescott R.
        Barriers to participation in randomised controlled trials: a systematic review.
        J Clin Epidemiol. 1999; 52: 1143-1156